NeuroScientific Biopharmaceuticals Limited (ASX:NSB) Remarkable Results from Patients Treated with StemSmart™ Under the Special Access Program
26 May 2026 Price Sensitive Announcement $ Highlights: Overview: NeuroScientific Biopharmaceuticals Limited, an innovative Australian biotechnology company developing novel technologies targeted at immune-mediated inflammatory diseases, is pleased to announce exceptional outcomes...
